SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Dr. Juan Manuel Pérez - 10 April, 2026 0

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Dr. Juan Manuel Pérez - 9 April, 2026 0

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Dr. Juan Manuel Pérez - 8 April, 2026 0

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

Noticias Institucionales

SOLACI invites you to the 5th International Conference on Clinical and Interventional Cardiology in the Dominican Republic

solaci - 6 April, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI) invites the community to the 5th International Conference on Clinical and Interventional Cardiology (Coronary and Structural),...

Panama Sessions 2026 – Young Interventional Cardiologists Contest. Submit Your Case

solaci - 31 March, 2026 0

The call for submissions is now open to participate in the Young Interventional Cardiologists Competition at the Panama 2026 Regional Meeting, which will take...

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

solaci - 29 March, 2026 0

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: DAPT

SOLACI Webinar – Innovation: Short Dual Therapy in Patients with High...

We Should Indicate More than 6 Months of DAPT in Lower...

ACC 2018 | SMART-DATE: 6 Month DAPT Results Suboptimal in ACS

Complex PCI: DAPT defining factor?

Angioplasty Complexity May Define the Duration of Dual Antiplatelet Therapy

TCT 2017 | REDUCE: 3 vs 12 Months of Dual Antiplatelet...

REDUCE Trial: Patients with PFO and cryptogenic stroke at lower...

Dual antiplatelet therapy discontinuation causes more thrombotic events at 12 months

Risk of Thrombosis and Bleeding with Peripheral Artery Disease and Concomitants

Dual Antiplatelet in TAVR: Is Single Better?